Overview
Quick‑onset viral conjunctivitis, often called “pink eye,” is an acute inflammation of the conjunctiva (the thin, transparent membrane that covers the white part of the eye and lines the inner eyelid) caused primarily by viruses. It appears suddenly, usually within 24–48 hours, and spreads easily in close‑contact settings such as schools, day‑care centers, and households.
Globally, viral conjunctivitis accounts for 50–80 % of all conjunctivitis cases and is the most common cause of infectious eye disease in both children and adults. In the United States, the Centers for Disease Control and Prevention (CDC) estimates that 2–3 million cases occur each year, with seasonal peaks in the fall and winter when respiratory viruses are circulating.1 The condition is non‑life‑threatening, but the rapid onset of symptoms can be distressing and may cause missed school or work days.
Symptoms
Symptoms typically begin suddenly and may affect one eye (unilateral) or both eyes (bilateral). The classic presentation includes:
- Redness (hyperemia): Diffuse pink or reddish hue of the sclera caused by dilation of conjunctival vessels.
- Watery discharge: Clear or slightly mucous tear‑like fluid; unlike bacterial conjunctivitis, the discharge is not thick or purulent.
- Itching or burning sensation: Mild to moderate discomfort that may feel gritty.
- Foreign‑body sensation: The feeling that something is in the eye.
- Photophobia: Sensitivity to bright light, more common when the cornea is involved.
- Swollen eyelids: Mild edema of the lids.
- Lacrimation (excess tearing): Increased tear production due to irritation.
- Pre‑auricular lymphadenopathy: Tender lymph nodes near the ear, especially in adenovirus infection.
- Conjunctival follicles: Small, raised, whitish bumps on the inner surface of the eyelid (seen on slit‑lamp exam).
Symptoms usually peak within the first 2–3 days and improve over 7–14 days. In rare cases, especially with adenoviral serotypes 8, 19, and 37, a longer course (up to 3 weeks) may occur.
Causes and Risk Factors
Viral agents
- Adenovirus: The most frequent culprit (≈75 % of viral cases). Subtypes 3, 4, 7, 8, 19, and 37 are especially ocular tropic.
- Enteroviruses (e.g., Coxsackie): More common in children.
- Epstein‑Barr virus (EBV) & Herpes simplex virus (HSV): Can cause conjunctivitis but usually present with additional signs (e.g., vesicular lesions).
- Varicella‑zoster virus (VZV): Causes “zoster‑associated conjunctivitis” in the setting of shingles.
Transmission pathways
- Direct contact with contaminated eye secretions.
- Touching a surface (doorknobs, toys, towels) then rubbing the eyes.
- Aerosolized droplets from coughing or sneezing (especially adenovirus).
Risk factors
- Age < 12 years (high contact rates in schools).
- Close‑quarter living or work environments (day‑care centers, military barracks).
- Recent upper‑respiratory infection (common prodrome).
- Contact lens wear, especially if hygiene is poor.
- Immunocompromised state (e.g., HIV, chemotherapy) may prolong illness.
Diagnosis
Diagnosis is primarily clinical, based on the rapid onset of symptoms and characteristic findings. A systematic approach includes:
History taking
- Onset and progression of symptoms.
- Recent upper‑respiratory infection or contact with an infected person.
- Exposure to contaminated objects or swimming pools.
- Contact lens use, eye trauma, or recent ocular surgery.
Physical examination
- Visual acuity testing to rule out corneal involvement.
- Slit‑lamp examination: looks for follicles, punctate epithelial erosions, and pre‑auricular lymph nodes.
- Eversion of the eyelid to assess discharge type.
Laboratory tests (used selectively)
- Polymerase chain reaction (PCR): Detects viral DNA/RNA from conjunctival swabs; high sensitivity for adenovirus.
- Rapid antigen detection kits: Provide results in 10–15 minutes for adenovirus (e.g., AdenoPlus™).
- Viral culture: Rarely performed because turnaround time is long.
- Serology: May be used for HSV or VZV when atypical features are present.
Testing is generally reserved for atypical cases, outbreaks in schools/workplaces, or when bacterial superinfection is suspected.
Treatment Options
Because viral conjunctivitis is self‑limiting, the mainstay of therapy is supportive care. No antiviral eye drops are approved for routine adenoviral infection, but certain situations warrant specific medication.
Supportive measures
- Cool compresses: Apply a clean, cold, damp cloth to closed eyelids for 5–10 minutes, 3–4 times daily to reduce swelling.
- Lubricating artificial tears: Preservative‑free drops restore comfort and flush out irritants.
- Hygiene: Frequent hand washing, avoid touching eyes, and change pillowcases daily.
Pharmacologic options
- Topical antihistamine/mast‑cell stabilizer drops: Helpful for itching when an allergic component coexists (e.g., olopatadine).
- Corticosteroid eye drops: Short course (≤7 days) may be prescribed by an ophthalmologist for severe inflammation or when there is concurrent keratitis; must be monitored for intra‑ocular pressure rise.
- Antiviral agents:
- Topical ganciclovir or oral valacyclovir are reserved for HSV or VZV conjunctivitis.
- Clinical trials of topical cidofovir for adenovirus have shown limited benefit and are not standard care.
Adjunctive therapies for complications
- Antibiotic eye drops: Not indicated for pure viral infection but may be used if a bacterial superinfection develops (e.g., fluoroquinolone drops).
- Topical lubricants with preservative‑free formulation: Reduce risk of corneal epithelial breakdown.
Living with Quick‑Onset Viral Conjunctivitis
While the infection resolves on its own, patients often need practical strategies to stay comfortable and prevent transmission.
Daily management tips
- Do not wear contact lenses until the discharge is completely cleared and a clinician gives the green light.
- Use separate towels for the affected eye; wash hands before and after applying any drops.
- Discard any makeup (mascara, eyeliner) that may have contacted the infected eye; replace with new products after recovery.
- Wear sunglasses outdoors to lessen photophobia.
- Maintain a regular sleep schedule and stay hydrated; systemic hydration supports tear production.
- If you work or attend school, follow local public‑health guidance—often 24 hours after symptoms appear and no discharge is present before returning.
When to see a primary‑care physician or ophthalmologist
- Symptoms persist beyond 14 days or worsen after the first week.
- Severe pain, sudden vision loss, or marked sensitivity to light.
- Presence of a thick, yellow/green discharge suggesting bacterial superinfection.
- History of ocular surgery, trauma, or immunosuppression.
Prevention
Because viral conjunctivitis spreads easily, preventive measures focus on hygiene and avoiding exposure.
- Hand hygiene: Wash hands with soap and water for at least 20 seconds after touching the eyes or cleaning secretions.
- Avoid sharing personal items: Towels, washcloths, eye makeup, and pillowcases.
- Disinfect surfaces: Use EPA‑approved disinfectants on high‑touch surfaces (doorknobs, keyboards) at least twice daily during an outbreak.
- Stay home when symptomatic: Follow CDC recommendations—generally 24 hours after symptoms start and no longer contagious when discharge has stopped.
- Contact lens care: Clean lenses with appropriate solution, replace cases monthly, and avoid wearing lenses while infected.
- Vaccination: No vaccine exists for adenoviral conjunctivitis, but routine immunizations (e.g., measles‑mumps‑rubella) reduce overall viral burden that can predispose to eye infection.
Complications
Although uncommon, untreated or severe cases can lead to:
- Keratitis: Inflammation of the cornea causing pain, blurred vision, and potential scarring.
- Subconjunctival hemorrhage: Small bleed under the conjunctiva, usually self‑limited.
- Chronic conjunctival scarring (symblepharon): May occur after severe adenoviral infection, potentially affecting eyelid movement.
- Secondary bacterial infection: Can worsen inflammation and require antibiotic therapy.
- Spread to the other eye: Approximately 30 % of unilateral cases become bilateral if hygiene is poor.
When to Seek Emergency Care
- Sudden loss of vision or a large area of blurred vision.
- Severe eye pain that does not improve with a cool compress.
- Marked swelling of the eyelid(s) that prevents the eye from opening.
- Intense photophobia with a gritty feeling that suggests corneal ulceration.
- Fever above 101 °F (38.5 °C) accompanied by redness and discharge, indicating possible systemic infection.
- Signs of an allergic reaction after using eye drops (e.g., rash, difficulty breathing).
References
- Centers for Disease Control and Prevention. Conjunctivitis (Pink Eye) – Fact Sheet. Updated 2023. https://www.cdc.gov/conjunctivitis
- Mayo Clinic. Viral conjunctivitis. Reviewed 2022. https://www.mayoclinic.org
- American Academy of Ophthalmology. Conjunctivitis (Pink Eye). 2023. https://www.aao.org
- World Health Organization. Prevention of Eye Infections. 2021. https://www.who.int
- Cleveland Clinic. Viral Pink Eye (Conjunctivitis) – Symptoms, Diagnosis, Treatment. 2022. https://my.clevelandclinic.org
- Jabri A, et al. Adenoviral conjunctivitis: current understanding and future directions. Ophthalmology Review. 2020;12(3):45‑52.
- Harper SJ, et al. Rapid antigen testing for adenoviral conjunctivitis: clinical performance. Clin Infect Dis. 2021;73(12):e4015‑e4022.